日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The CD4/CD8 ratio is associated with T lymphocyte functions in long-term virally suppressed patients with HIV

CD4/CD8 比值与长期病毒抑制的 HIV 感染者的 T 淋巴细胞功能相关。

Xiao, Qing; Yu, Fengting; Yan, Liting; Lao, Xiaojie; Liang, Xuelei; Zhao, Hongxin; Zhai, Liuyue; Yang, Zailin; Zhang, Xiaomei; Liu, Yao; Zhang, Fujie

Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial

ER+HER2 转移性乳腺癌中赖氨酸乙酰转移酶 KAT6 的抑制:一项 1 期试验

Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon

Rhein: An Updated Review Concerning Its Biological Activity, Pharmacokinetics, Structure Optimization, and Future Pharmaceutical Applications

大黄素:关于其生物活性、药代动力学、结构优化和未来药物应用的最新综述

Fu, Yuqi; Yang, Le; Liu, Lei; Kong, Ling; Sun, Hui; Sun, Ye; Yin, Fengting; Yan, Guangli; Wang, Xijun

Elucidating the Gene Signatures and Immune Cell Types in HIV-Infected Immunological Non-Responders by Bioinformatics Analyses

通过生物信息学分析阐明HIV感染免疫无应答者的基因特征和免疫细胞类型

Xiao, Qing; Han, Junyan; Yu, Fengting; Yan, Liting; Li, Qun; Lao, Xiaojie; Zhao, Hongxin; Zhang, Fujie

Persistent Low-Level Viremia is an Independent Risk Factor for Virologic Failure: A Retrospective Cohort Study in China

持续低水平病毒血症是病毒学失败的独立危险因素:一项中国回顾性队列研究

Li, Qun; Chen, Meiling; Zhao, Hongxin; Yu, Fengting; Yan, Liting; Xiao, Jiang; Gao, Guiju; Yang, Di; Zhang, Fujie

Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients

SARS-CoV-2感染患者体内病毒的定量检测和病毒载量分析

Yu, Fengting; Yan, Liting; Wang, Nan; Yang, Siyuan; Wang, Linghang; Tang, Yunxia; Gao, Guiju; Wang, Sa; Ma, Chengjie; Xie, Ruming; Wang, Fang; Tan, Chianru; Zhu, Lingxiang; Guo, Yong; Zhang, Fujie

Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma

蛋白质精氨酸甲基转移酶 PRMT5 作为胶质母细胞瘤候选治疗靶点的基因验证

Fengting Yan, Lapo Alinari, Mark E Lustberg, Ludmila Katherine Martin, Hector M Cordero-Nieves, Yeshavanth Banasavadi-Siddegowda, Selene Virk, Jill Barnholtz-Sloan, Erica Hlavin Bell, Jeffrey Wojton, Naduparambil K Jacob, Arnab Chakravarti, Michal O Nowicki, Xin Wu, Rosa Lapalombella, Jharna Datta, 

PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.)

PRMT5 在恶性和转移性黑色素瘤中上调,并调节 MITF 和 p27(Kip1)的表达。

Courtney Nicholas, Jennifer Yang, Sara B Peters, Matthew A Bill, Robert A Baiocchi, Fengting Yan, Saïd Sïf, Sookil Tae, Eugenio Gaudio, Xin Wu, Michael R Grever, Gregory S Young, Gregory B Lesinski